Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy

Xiangling Xiao^#^{1

2}, Jie Shi^#^{1

2}, Chuan He^#^{1

2}, Xia Bu³, Yishuang Sun^{1

2}, Minling Gao^{1

2}, Bolin Xiang^{1

2}, Wenjun Xiong^{1

2}, Panpan Dai¹, Qi Mao^{1

2}, Xixin Xing^{1

2}, Yingmeng Yao^{1

2}, Haisheng Yu^{1

2}, Gaoshan Xu^{1

2}, Siqi Li⁴, Yan Ren⁵, Baoxiang Chen⁶, Congqing Jiang⁶, Geng Meng⁷, Yu-Ru Lee⁸, Wenyi Wei⁹, Gordon J Freeman³, Conghua Xie¹⁰, Jinfang Zhang^{11

12}

Affiliations

¹ Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan University, Wuhan, 430071, China.
² Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430071, China.
³ Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
⁴ Department of Biology, University of Copenhagen, Copenhagen, 2100, Denmark.
⁵ Experiment Center for Science and Technology, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
⁶ Department of Colorectal and Anal Surgery, Low Rectal Cancer Diagnosis and Treatment Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
⁷ College of Veterinary Medicine, China Agricultural University, Beijing, 100094, China.
⁸ Institute of Biomedical Sciences, Academia Sinica, Taipei, 115201, Taiwan.
⁹ Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02115, USA.
¹⁰ Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan University, Wuhan, 430071, China. chxie_65@whu.edu.cn.
¹¹ Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan University, Wuhan, 430071, China. jinfang_zhang@whu.edu.cn.
¹² Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430071, China. jinfang_zhang@whu.edu.cn.

^# Contributed equally.

PMID: 40541949
PMCID: PMC12181289
DOI: 10.1038/s41467-025-61049-w

Published Erratum

Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy

Xiangling Xiao et al. Nat Commun. 2025.

. 2025 Jun 20;16(1):5357.

doi: 10.1038/s41467-025-61049-w.

Authors

Affiliations

¹ Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan University, Wuhan, 430071, China.
² Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430071, China.
³ Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
⁴ Department of Biology, University of Copenhagen, Copenhagen, 2100, Denmark.
⁵ Experiment Center for Science and Technology, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
⁶ Department of Colorectal and Anal Surgery, Low Rectal Cancer Diagnosis and Treatment Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
⁷ College of Veterinary Medicine, China Agricultural University, Beijing, 100094, China.
⁸ Institute of Biomedical Sciences, Academia Sinica, Taipei, 115201, Taiwan.
⁹ Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02115, USA.
¹⁰ Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan University, Wuhan, 430071, China. chxie_65@whu.edu.cn.
¹¹ Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University; Medical Research Institute, Frontier Science Center of Immunology and Metabolism, Wuhan University, Wuhan, 430071, China. jinfang_zhang@whu.edu.cn.
¹² Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430071, China. jinfang_zhang@whu.edu.cn.

^# Contributed equally.

PMID: 40541949
PMCID: PMC12181289
DOI: 10.1038/s41467-025-61049-w

No abstract available

PubMed Disclaimer

Erratum for

ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy.
Xiao X, Shi J, He C, Bu X, Sun Y, Gao M, Xiang B, Xiong W, Dai P, Mao Q, Xing X, Yao Y, Yu H, Xu G, Li S, Ren Y, Chen B, Jiang C, Meng G, Lee YR, Wei W, Freeman GJ, Xie C, Zhang J. Xiao X, et al. Nat Commun. 2023 May 19;14(1):2859. doi: 10.1038/s41467-023-38605-3. Nat Commun. 2023. PMID: 37208329 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- PubMed Central
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy

Affiliations

Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Miscellaneous